Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector contract development and manufacturing organization (CDMO) specializing in advanced therapies, is pleased to announce its engagement ...

Parks will spearhead development and execution of Matica Bio’s commercial strategic initiatives as EVP of Commercial Operations Sugrue to advance business development goals, partnerships as VP of ...

COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the GMP production of cell and gene ...

CHA Biotech said on the 3rd that its U.S. subsidiary Matica Biotechnology signed a CDMO (contract development and manufacturing) deal with Kalidi Biotherapeutics. Kalidi develops oncolytic virus ...

A lack of global capacity to produce cell and gene therapies has been exacerbated by an even more pressing need: to develop and manufacture coronavirus vaccines. So it appears the timing is right for ...

Kim to oversee cell and gene therapy (CGT) manufacturing operations, processes, operations, and business strategy as CEO during period of rapid expansion across US and Korea COLLEGE STATION, ...

Matica Biotechnology, a U.S. affiliate of Korea’s CHA Biotech, said Tuesday that it has signed a contract development and manufacturing deal with Cirsium Biosciences, a U.S. biotech firm developing ...